Product Images Tizanidine

The text describes a figure showing the mean concentration of Tizanidine over time for tablets and capsules of 2 x 4 mg dosage under fasted and fed conditions.*

The text describes a figure (Figure 2) that displays data from a single-dose study, showing the mean change in muscle tone from the baseline (as measured by the Ashworth Scale) over time (in hours post-dose). The scale is measured on a negative scale, where a lower score indicates an improvement in muscle tone from the baseline. The figure also includes a 95% confidence interval. No further information is available.*

These tablets contain 2 mg of tizanidine base equivalent to 2.268 mg of tizanidine hydrochloride. They should be stored between 20-25°C (68-77°F) with limited excursions from 15-30°C (59-86°F). They must be kept in a tight and light-resistant container. The usual dosage instructions are included in the package. These tablets should not be confused with tizanidine capsules or Zanaflex capsules and are a product of Apotex Corp.*

This is a description of the medication Tizanidine. Each tablet contains 4 mg of Tizanidine hydrochloride, and they must be stored in a container at controlled room temperature. The usual dosage is specified on the package insert. It is a registered trademark of Acorda Therapeutics Inc. The medicine comes in a pack of 150 tablets made by Apotex Corp. The capsules are not interchangeable with that of Tizani capsules or Zanaflex capsules.*